Mohit Verma

Mohit Verma is an experienced professional in the field of immuno-oncology and preclinical drug development, currently serving as Director at ImmunityBio, Inc. since June 2019. In this capacity, Mohit provides strategic and technical leadership for planning and executing preclinical studies supporting IND submissions, while facilitating collaboration between R&D and clinical teams. Prior experience includes roles as Associate Director and Manager at Genesis Biotechnology Group, where Mohit led the development of multiple preclinical CRO products and scientific cores. As a Research Scientist at The Jackson Laboratory, Mohit focused on cancer model development, securing funding and achieving significant collaborative milestones. Mohit's academic background includes a Ph.D. in Anatomic Pathology/Oncology from Tohoku University, where research efforts led to the identification of novel biomarkers in lung cancer. Mohit has received numerous awards for contributions to cancer research and development, including funding from reputable institutions.